327 related articles for article (PubMed ID: 37928545)
1. Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process.
Gu M; Jin Y; Gao X; Xia W; Xu T; Pan S
Front Immunol; 2023; 14():1278521. PubMed ID: 37928545
[TBL] [Abstract][Full Text] [Related]
2. Current Understanding of IL-37 in Human Health and Disease.
Su Z; Tao X
Front Immunol; 2021; 12():696605. PubMed ID: 34248996
[TBL] [Abstract][Full Text] [Related]
3. Insight into interleukin-37: The potential therapeutic target in allergic diseases.
Huang Z; Xie L; Li H; Liu X; Bellanti JA; Zheng SG; Su W
Cytokine Growth Factor Rev; 2019 Oct; 49():32-41. PubMed ID: 31672283
[TBL] [Abstract][Full Text] [Related]
4. IL-37: An anti-inflammatory cytokine with antitumor functions.
Mei Y; Liu H
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1151. PubMed ID: 32935478
[TBL] [Abstract][Full Text] [Related]
5. IL-37 As a Potential Biotherapeutics of Inflammatory Diseases.
Bai J; Li Y; Li M; Tan S; Wu D
Curr Drug Targets; 2020; 21(9):855-863. PubMed ID: 32348214
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of interleukin-37 in cardiovascular diseases.
Zhuang X; Wu B; Li J; Shi H; Jin B; Luo X
Immun Inflamm Dis; 2017 Sep; 5(3):373-379. PubMed ID: 28548248
[TBL] [Abstract][Full Text] [Related]
7. Suppression of inflammation and acquired immunity by IL-37.
Cavalli G; Dinarello CA
Immunol Rev; 2018 Jan; 281(1):179-190. PubMed ID: 29247987
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology.
Voronov E; Apte RN
Curr Pharm Des; 2017; 23(32):4893-4905. PubMed ID: 28606052
[TBL] [Abstract][Full Text] [Related]
9. A protective role of IL-37 in cancer: a new hope for cancer patients.
Abulkhir A; Samarani S; Amre D; Duval M; Haddad E; Sinnett D; Leclerc JM; Diorio C; Ahmad A
J Leukoc Biol; 2017 Feb; 101(2):395-406. PubMed ID: 27881603
[TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.
Conti P; Carinci F; Lessiani G; Spinas E; Kritas SK; Ronconi G; Caraffa A; Theoharides TC
Immunol Res; 2017 Oct; 65(5):982-986. PubMed ID: 28748328
[TBL] [Abstract][Full Text] [Related]
11. IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction.
Nold-Petry CA; Lo CY; Rudloff I; Elgass KD; Li S; Gantier MP; Lotz-Havla AS; Gersting SW; Cho SX; Lao JC; Ellisdon AM; Rotter B; Azam T; Mangan NE; Rossello FJ; Whisstock JC; Bufler P; Garlanda C; Mantovani A; Dinarello CA; Nold MF
Nat Immunol; 2015 Apr; 16(4):354-65. PubMed ID: 25729923
[TBL] [Abstract][Full Text] [Related]
12. Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.
Varvara G; Tettamanti L; Gallenga CE; Caraffa Al; D'Ovidio C; Mastrangelo F; Ronconi G; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2018; 32(6):1355-1360. PubMed ID: 30574739
[TBL] [Abstract][Full Text] [Related]
13. The role of IL-37 in skin and connective tissue diseases.
Pan Y; Wen X; Hao D; Wang Y; Wang L; He G; Jiang X
Biomed Pharmacother; 2020 Feb; 122():109705. PubMed ID: 31918276
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
15. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.
Conti P; Ronconi G; Caraffa A; Gallenga CE; Ross R; Frydas I; Kritas SK
J Biol Regul Homeost Agents; 2020 March-April,; 34(2):327-331. PubMed ID: 32171193
[TBL] [Abstract][Full Text] [Related]
16. Mast cell in innate immunity mediated by proinflammatory and antiinflammatory IL-1 family members.
Robuffo I; Toniato E; Tettamanti L; Mastrangelo F; Ronconi G; Frydas I; Caraffa Al; Kritas SK; Conti P
J Biol Regul Homeost Agents; 2017; 31(4):837-842. PubMed ID: 29254286
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.
Ge Y; Huang M; Yao YM
Cytokine Growth Factor Rev; 2019 Feb; 45():24-34. PubMed ID: 30587411
[TBL] [Abstract][Full Text] [Related]
18. Dual role of IL-37 in the progression of tumors.
Zhu Y; Qin H; Ye K; Sun C; Qin Y; Li G; Wang H; Wang H
Cytokine; 2022 Feb; 150():155760. PubMed ID: 34800851
[TBL] [Abstract][Full Text] [Related]
19. Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP.
Fabbi M; Carbotti G; Ferrini S
J Leukoc Biol; 2015 Apr; 97(4):665-75. PubMed ID: 25548255
[TBL] [Abstract][Full Text] [Related]
20. The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines.
Sharma S; Kulk N; Nold MF; Gräf R; Kim SH; Reinhardt D; Dinarello CA; Bufler P
J Immunol; 2008 Apr; 180(8):5477-82. PubMed ID: 18390730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
